1. Home
  2. ARQT vs EVTC Comparison

ARQT vs EVTC Comparison

Compare ARQT & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • EVTC
  • Stock Information
  • Founded
  • ARQT 2016
  • EVTC 1988
  • Country
  • ARQT United States
  • EVTC United States
  • Employees
  • ARQT N/A
  • EVTC N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • ARQT Health Care
  • EVTC Technology
  • Exchange
  • ARQT Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • ARQT 2.1B
  • EVTC 2.1B
  • IPO Year
  • ARQT 2020
  • EVTC 2013
  • Fundamental
  • Price
  • ARQT $17.71
  • EVTC $33.85
  • Analyst Decision
  • ARQT Strong Buy
  • EVTC Hold
  • Analyst Count
  • ARQT 7
  • EVTC 5
  • Target Price
  • ARQT $19.00
  • EVTC $39.00
  • AVG Volume (30 Days)
  • ARQT 1.6M
  • EVTC 281.6K
  • Earning Date
  • ARQT 11-05-2025
  • EVTC 11-05-2025
  • Dividend Yield
  • ARQT N/A
  • EVTC 0.59%
  • EPS Growth
  • ARQT N/A
  • EVTC 102.95
  • EPS
  • ARQT N/A
  • EVTC 2.13
  • Revenue
  • ARQT $263,464,999.00
  • EVTC $886,589,000.00
  • Revenue This Year
  • ARQT $72.46
  • EVTC $9.23
  • Revenue Next Year
  • ARQT $31.69
  • EVTC $4.84
  • P/E Ratio
  • ARQT N/A
  • EVTC $15.91
  • Revenue Growth
  • ARQT 99.50
  • EVTC 12.93
  • 52 Week Low
  • ARQT $8.03
  • EVTC $31.41
  • 52 Week High
  • ARQT $18.15
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 63.97
  • EVTC 42.88
  • Support Level
  • ARQT $16.62
  • EVTC $33.31
  • Resistance Level
  • ARQT $18.15
  • EVTC $34.48
  • Average True Range (ATR)
  • ARQT 0.69
  • EVTC 0.69
  • MACD
  • ARQT 0.03
  • EVTC -0.13
  • Stochastic Oscillator
  • ARQT 85.57
  • EVTC 25.68

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: